Detalles de la búsqueda
1.
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer.
Breast Cancer Res Treat;
204(3): 539-546, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38198070
2.
Exploring breast tissue microbial composition and the association with breast cancer risk factors.
Breast Cancer Res;
25(1): 82, 2023 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37430354
3.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat;
202(1): 191-201, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589839
4.
Breast Cancer Worry in U.S. Female First-degree Relatives: Moderating Role of Daily Spiritual Experiences.
J Relig Health;
62(5): 3466-3479, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014487
5.
Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence.
Breast Cancer Res;
24(1): 45, 2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35821041
6.
Serum hormone levels and normal breast histology among premenopausal women.
Breast Cancer Res Treat;
194(1): 149-158, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35503494
7.
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.
Support Care Cancer;
30(10): 8059-8067, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776183
8.
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Breast Cancer Res;
22(1): 22, 2020 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32070401
9.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat;
181(3): 623-633, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378051
10.
Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.
Breast Cancer Res Treat;
176(3): 617-624, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079282
11.
Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
Int J Cancer;
143(3): 496-507, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473153
12.
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.
Breast Cancer Res Treat;
167(1): 107-116, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28918548
13.
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
Breast Cancer Res Treat;
171(1): 121-129, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752687
14.
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.
Support Care Cancer;
26(6): 1993-2004, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29327085
15.
Metastatic breast cancer patients' expectations and priorities for symptom improvement.
Support Care Cancer;
26(11): 3781-3788, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29736866
16.
Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast.
Int J Cancer;
140(4): 825-832, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859137
17.
DNA methylation age is elevated in breast tissue of healthy women.
Breast Cancer Res Treat;
164(1): 209-219, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28364215
18.
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients.
Breast Cancer Res Treat;
165(3): 659-668, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28643023
19.
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors.
Breast Cancer Res Treat;
164(2): 411-419, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28451964
20.
Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibility.
Psychooncology;
26(11): 1944-1951, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27648927